Venmax Drugs and Pharmaceuticals Limited (VENMAX) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE154G01022
₹14.12+0.19 (+1.36%)
Key metrics
- Market Cap
- ₹13 Cr
- P/E Ratio
- 60.42
- EPS
- 0.24
- Book Value
- 16.07
- P/B Ratio
- 0.87
- ROE
- 1.76%
- ROCE
- 0.81%
- Debt / Equity
- 0.02
- Net Margin
- 3.09%
- Revenue Growth
- 894.04%
- Profit Growth
- 2,463.81%
- Dividend Yield
- —
- 52W High
- ₹31.49
- 52W Low
- ₹13.52
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Venmax Drugs and Pharmaceuticals Limited
Venmax Drugs and Pharmaceuticals Limited engages in the business of pharmaceutical products, drug intermediaries, and API's. The company was formerly known as Yenkey Drugs & Pharmaceuticals Ltd and changed its name to Venmax Drugs and Pharmaceuticals Limited in April 2009. Venmax Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 59.91%
The full Venmax Drugs and Pharmaceuticals Limited analysis
Create a free account to open the complete VENMAX deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.